GFAP and Alzheimer disease: Our IF results (Figure 6 and S7) indicated the co‐localization of S1PR1 with GFAP (astrocyte) or IBA‐1 (microglia), further suggesting EA may improve cognitive and memory functions of AD by modulating astrocyte or microglia‐related functions.